Effects of CD20 antibodies and kinase inhibitors on B‐cell receptor signalling and survival of chronic lymphocytic leukaemia cells-Reference-Cited by-同舟云学术

Effects of CD20 antibodies and kinase inhibitors on B‐cell receptor signalling and survival of chronic lymphocytic leukaemia cells

Published:2020-11-20 Issue:2 Volume:192 Page:333-342
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Cavallini Chiara¹^ORCID,Galasso Marilisa²,Pozza Elisa Dalla²,Chignola Roberto³,Lovato Ornella¹,Dando Ilaria²,Romanelli Maria G.²,Krampera Mauro⁴,Pizzolo Giovanni⁴,Donadelli Massimo²,Scupoli Maria T.¹²^ORCID

Affiliation:

1. Research Center LURM (Interdepartmental Laboratory of Medical Research) University of Verona Verona Italy

2. Department of Neurosciences, Biomedicine and Movement Sciences University of Verona Verona Italy

3. Department of Biotechnology University of Verona Verona Italy

4. Department of Medicine Section of Hematology University of Verona Verona Italy

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17139

Reference56 articles.

1. The 2016 revision of the World Health Organization classification of lymphoid neoplasms

2. National Cancer Institute.Cancer Stat Facts: leukemia ‐ Chronic Lymphocytic Leukemia (CLL). Available from:https://seer.cancer.gov/statfacts/html/clyl.html.

3. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment

4. Chronic lymphocytic leukaemia

5. Effector mechanisms of anti-CD20 monoclonal antibodies in B cell malignancies

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. G protein-coupled receptor 183 mediates the sensitization of Burkitt lymphoma tumors to CD47 immune checkpoint blockade by anti-CD20/PI3Kδi dual therapy;Frontiers in Immunology;2023-04-21

2. Simultaneous crosslinking of CD20 and CD38 receptors by drug-free macromolecular therapeutics enhances B cell apoptosis in vitro and in vivo;Journal of Controlled Release;2022-10

3. Phospho-Specific Flow Cytometry Reveals Signaling Heterogeneity in T-Cell Acute Lymphoblastic Leukemia Cell Lines;Cells;2022-06-29

4. The resistance mechanisms and treatment strategies of BTK inhibitors in B‐cell lymphoma;Hematological Oncology;2021-10-15

5. The future of antibody therapy in chronic lymphocytic leukemia;Expert Opinion on Emerging Drugs;2021-07-03